|
|
 |
|
Viewing report
|
|
|
|
South Africa Pharmaceuticals and Healthcare Report Q3 2008
Business Monitor International, June 2008, Pages: 96
'Executive Summary
South Africa Political SWOT
South Africa Economic SWOT
South Africa Business Environment SWOT
Pharmaceutical Business Environment Ratings
Table: Pharmaceutical Business Environment Ratings
Limits To Potential Returns
Risks To Realisation Of Returns
South Africa – Market Summary
Regulatory Regime
Table: South Africa Drug Classification System (Section 22A Of Medicines And Reated Substance Act 101 Of 1965)
Recent Regulatory Developments
Proposed Scope Of the South African Health products Regulatory
Intellectual Property Environment
Compulsory Licensing
Counterfeit Activity
Pricing System
Reimbursement System
Recent Pricing And Reimbursement Developments
Table: Companies Involved In South Africa’s February 2008 Price Fixing Scandal
Industry Developments
Epidemiology
Table: Leading Causes Of Disease In Africa, 2002
HIV/AIDS
Tuberculosis
Healthcare Sector
Recent Healthcare Sector Developments
Health Insurance
Government Health Insurance
Recent Insurance Industry Developments
Pharmaceutical Sector
Table: PIASA Membership
ARV Manufacturing and Government Tenders
Table: Results Of South Africa’s HIV/AIDS Drug Tender, March 2005
Domestic Company Developments
Key Facts: Stategic Partnership Between Strides Arcolab And Aspen Pharmacare
Foreign Company Developments
Retail Pharmacy Sector
Research And Development Sector
AIDS/HIV Research
Vaccines
Traditional African Medicine
Medical Devices
Table: South African Customs Classification Of Medical Devices
Regional Developments in Medical Devices Sector
Table: Aims Of PEPFAR-BD Partnership
Industry Forecast Scenario
Overall Market Forecast
Table: Drug Expenditure And Prescription Market Indicators (US$mn unless otherewise stated)
Key Growth Factors – Industry
Table: Health Expenditure Indicators, 2006-2012
Key Growth Factors – Macroeconomic
Table: South Africa – Economic Activity
Patented Market Forecast
Table: South Africa’s Prescription Drug Market Forecast Indicators (US$mn unless otherwise stated)
Generics Market Forecast
Table: South Africa’s Generic Drug Market, 2006-2012
OTC Market Forecast
Table: South Africa’s OTC Drug Market Indicators, 2006-2012 (US$mn unless otherwise stated)
Medical Device Forecast
Table: South Africa’s Medical Device Market, 2005-2012 (US$mn unless otherwise stated)
Export/Import Forecasts
Table: South Africa’s Export And Import Trade Indicators, 2006-2012 (US$mn)
Other Healthcare Data
Table: General Healthcare Indicators, 2006-2012
Key Risks To BMI’s Forecast Scenario
Competitive Landscape
Table: Top 10 Drugmakers In South Africa, 2006
Company Monitor
Leading Foreign Companies
Sanofi-Aventis
Pfizer
Roche
GlaxoSmithKline
Merck & Co
Leading Indigenous Manufacturers
Aspen Pharmacare
Adcock Ingram
Enaleni Pharmaceuticals
BMI Forecast Modelling
How We Generate Our Pharmaceutical Industry Forecasts
Pharmaceutical Business Environment Ratings Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Weighting
Table: Weighting Of Components
Sources
Also available
South Korea Pharmaceuticals and Healthcare Report Q1 2008
Customers who bought this item also bought
The Pharmaceutical Market: South Africa
South Africa Pharmaceuticals and Healthcare Report Q4 2008
South Africa Pharmaceuticals and Healthcare Report Q4 2009
South Africa Pharmaceuticals and Healthcare Report Q1 2008
South Africa Pharmaceuticals and Healthcare Report Q3 2007
Analgesics in South Africa
Eye Care in South Africa
Wound Treatments in South Africa
Vitamins and Dietary Supplements in South Africa
Medicated Skin Care in South Africa
South Africa Pharmaceuticals and Healthcare Report Q1 2009
The Medical Device Market: South Africa
|
|
|
|
